CLC Number:
| [1] 李小毛,叶辉霞,刘继红,等.术前血清CA19-9在子宫内膜癌评估中的价值[J].中山大学学报(医学科学版),2015,36(2):275-278. LI Xiaomao, YE Huixia, LIU Jihong, et al. Serum Levels of CAl9-9 and Disease Characteristics in Endometrial Cancer[J]. Journal of Sun Yat-Sen University(Medical Sciences), 2015, 36(2):275-278. [2] Castel M, Despas F, Modesto A, et al.cardiotoxicity of chemotherapies[J].Presse Med, 2013, 42(1):26-39. [3] Schlitt A, Jordan K, Vordermark D, et al. Cardiotoxicity and oncological treatments[J].Dtsch Arztebl Int, 2014, 111(10):161-168. [4] Li WJ, Jiang JY, Wang XL.Nedaplatin salvage chemotherapy for cervical cancer[J].Asian Pac J Cancer Prev, 2015, 16(8):3159-3162. [5] Du J, Hu C, Zhang Y, et al. A retrospective study of paclitaxel combining nedaplatin chemotherapy for esophageal cancer[J]. Anticancer Drugs, 2015, 26(1):101-105. [6] 张雪花,王秀芬.奈达铂致心律失常1例[J].中国药物应用与监测, 2004(4):43-44. [7] 李捷, 欧阳学农, 余宗阳.国产奈达铂致严重过敏反应l例[J].药物流行病学杂志,2006,15(5):312-313. [8] 郭继鸿.左束支阻滞性心肌病[J].临床心电学杂志,2013,22(4):299-308. [9] Engel TR, Wolf NM.Left bundle branch block does not mean left coronary artery block[J].J Am Coll Cardiol, 2013, 62(11):968-969. [10] 潘志明.应用双源冠脉 CTA 图像测定研究心包内脂肪与冠脉斑块及狭窄程度的关系[J].实用医学杂志,2015,31(12):1990-1992. [11] Singh RM, Singh BM, Mehta JL. Role of cardiac CTA in estimating left ventricular volumes and ejection fraction[J].World J Radiol, 2014, 6(9):669-676. |
| No related articles found! |
|
||
